Tompkins Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-160	Closed	-$17K	–	430
2018 Q1	$17K	Buy	+160	New	+$17K	﹤0.01%	333
2016 Q3	–	Sell	-56	Closed	-$4K	–	433
2016 Q2	$4K	Buy	+56	New	+$4K	﹤0.01%	463